Aquestive Therapeutics AQST
NASDAQ AQST
$3.56 +0.04 (+1.14%)
As of: Nov 11, 2026 · 3:11 PM EST

Aquestive Therapeutics (AQST) Price to Book (2018)

Updated

Aquestive Therapeutics' (AQST) Price to Book came in at 12.95 for Q4 2018, down 30.5% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Price to Book (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Aquestive Therapeutics 442.42 Mn 21.68 Mn 3.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 12.95
Sep 30, 2018 18.63
API Access

Aquestive Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=AQST&period=max&api_key=YOUR_API_KEY